Yesterday | KHWB-TV Houston
Skin cells turned into beating heart cells
Dr. Lior Gepstein and his team at Technion-Israel Institute of Technology managed to take skin cells from ailing heart patients and by adding three genes and valproic acid , they turned the cells into beating heart tissue.
Business Week Article States That Manufacturer of Depakote Agrees to ...
Business Week Article States That Manufacturer of Depakote Agrees to Pay $1.6 Billion to Settle Government Investigations, Consumer Justice Foundation Reports The CJF further reports that Business Week has published an article stating that Abbott Laboratories, the manufacturer of Depakote, has agree to pay a $1.6 billion settlement to the ... (more)
W.Va. to get $1 million in Depakote settlement
Abbott Laboratories is paying $1.5 billion to resolve criminal and civil liability arising from its marketing of the prescription drug Depakote.
Check Up: A big fine and patent breaking highlight pharma's week
The perfect storm into which pharma has navigated itself means that the most constructive observations ought to point out potentially fruitful, new directions for the industry.
Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6...
Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement With Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote /PRNewswire/ -- In what may be the largest payment ever enforced involving off-label misuse of a single drug, law firm Grant & Eisenhofer , working with the U.S. Justice ... (more)
Abbott Laboratories settles consumer suit for $1.9M, Medicaid suit for $4.9M
Attorney General Greg Zoeller announced recently that the State of Indiana will recoup millions of dollars in two separate settlements of multistate lawsuits against pharmaceutical maker Abbott Laboratories over illegal off-label marketing of its drug, Depakote.
Abbott Laboratories: GMI Ratings
Abbott Laboratories Inc. pleaded guilty and agreed to pay $1.5 billion to resolve allegations that it illegally promoted the drug Depakote.
Arkansas attorney general announces settlement
LITTLE ROCK, Ark. - Arkansas Attorney General Dustin McDaniel has announced the settlement of two cases involving the pharmaceutical company Abbot Laboratories.
Iowa Will Get $1.4M in Drug-marketing Settlement
Iowa will receive more than $1.4 million from Abbott Laboratories to settle concerns that it improperly marketed its anti-seizure drug Depakote.
Drugs that can make you gain weight
About 70 percent of people in the United States are overweight and, in a cruel catch-22, many of the drugs used to treat obesity-linked conditions such as diabetes, high blood pressure, and depression can themselves cause weight gain.
The Briefcase: N.C. to get $3.5 million in drug settlement
The N.C. Attorney General's Office said Monday that Abbott Laboratories will pay North Carolina about $3.5 million to resolve allegations that it improperly marketed the drug Depakote.
Abbott Pleads Guilty, Settles for $1.6 Billion, but No Individuals Suffer Negative Consequences
Once again, another big US health care organization is set to make a huge legal settlement .
Abbott Labs to Pay $100 Million to Settle Off-Label Charges
Pharmaceutical company Abbott Labs has agreed to a $100 million settlement with 45 states and the District of Columbia for the illegal off-label marketing of its drug Depakote.
Texas dog honored as 30th National Hero Dog
A roiling political landscape in Europe is sending U.S. stock futures lower, with the parliament now split in economically fragile Greece and the election of Socialist as president in France.
State to Receive More Than $2.3 Million from Settlements with Abbott Laboratories
Attorney General Peter F. Kilmartin today joined fellow attorneys general in announcing two settlements with Abbott Laboratories over allegations of illegal off-label marketing of its drug, Depakote.
Oregon part of $100-million drug settlement
Oregon Attorney General John Kroger announced on Monday a $100 million multistate agreement with global health care and medical research company Abbott Laboratories over off-label promotional claims related to its drug Depakote.
D-Pharm Ltd. Receives First Payment for Epilepsy Drug, DP-VPA From Its Chinese Partner
Rehovot, Israel May 3rd, 2012 -- D-Pharm Ltd., announced today that it has received the first payment of $1M from Jiangsu NHWA Pharmaceutical Co., Ltd.
Also on Topix